Allergy/Imm Medical News about Eczema

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Eczema: what lies beneath
Nurse Prescribing, 10/08/09

Greener m – Eczema is one of the most common dermatological diseases and the number of cases has risen markedly over recent years. Emollients and topical steroids are the first–line treatments for mild–to–moderate eczema. Emollients reduce itching and irritation, rehydrate skin, protect against further drying and may reduce the need for topical steroids by up to 50%. Some eczema patients respond adequately to emollients alone. However, patients with moderate–to–severe eczema, and those who do not respond to first–line treatments, might require second–line therapies, such as calcineurin inhibitors, ultraviolet phototherapy and systemic drugs. The inflammatory changes that cause eczema may persist between flares. Therefore, patients with mild–to–moderate eczema can now apply tacrolimus proactively to skin areas prone to flare and that previously responded to the calcineurin inhibitor to reduce the frequency and severity of exacerbations.

<< Previous
Assessment of component-resolved in vitro diagnosis of celeriac...

Next >>
Virus-like particle vaccines and adjuvants: the HPV paradigm